Stock BMY BRISTOL-MYERS SQUIBB COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Bristol-Myers Squibb Company Berne S.E.

Equities

BMY

US1101221083

Delayed Berne S.E.
Other stock markets
 12:00:01 2024-02-21 EST 		5-day change 1st Jan Change
44.08 CHF +2.55% Intraday chart for Bristol-Myers Squibb Company -.--% -6.91%
06-22 Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI®? in Combination with Cetuximab for Adult Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or Metastatic Colorectal Cancer CI
06-21 Bristol-Myers Squibb's Colorectal Cancer Therapy Receives FDA Approval MT

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BMY Stock
  4. BMY Stock
  5. News Bristol-Myers Squibb Company
  6. MarketScreener Strategies